Clinical isolates of Streptococcus mitis/oralis -related species with reduced carbapenem susceptibility, harboring amino acid substitutions in penicillin-binding proteins in Japan.

MLA

Sarangi, Jayathilake, et al. “Clinical Isolates of Streptococcus Mitis/Oralis -Related Species with Reduced Carbapenem Susceptibility, Harboring Amino Acid Substitutions in Penicillin-Binding Proteins in Japan.” Antimicrobial Agents and Chemotherapy, vol. 68, no. 4, Apr. 2024, p. e0117923. EBSCOhost, https://doi.org/10.1128/aac.01179-23.

APA

Sarangi, J., Ido, A., Ito, M., Iinuma, C., Doyama, Y., Jin, W., Wachino, J.-I., Suzuki, M., Iguchi, M., Yagi, T., Arakawa, Y., & Kimura, K. (2024). Clinical isolates of Streptococcus mitis/oralis -related species with reduced carbapenem susceptibility, harboring amino acid substitutions in penicillin-binding proteins in Japan. Antimicrobial Agents and Chemotherapy, 68(4), e0117923. https://doi.org/10.1128/aac.01179-23

Chicago

Sarangi, Jayathilake, Ayaka Ido, Masaya Ito, Chihiro Iinuma, Yo Doyama, Wanchun Jin, Jun-Ichi Wachino, et al. 2024. “Clinical Isolates of Streptococcus Mitis/Oralis -Related Species with Reduced Carbapenem Susceptibility, Harboring Amino Acid Substitutions in Penicillin-Binding Proteins in Japan.” Antimicrobial Agents and Chemotherapy 68 (4): e0117923. doi:10.1128/aac.01179-23.